Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 25, 2009

Syngenta Adds MS Data Analysis System from Genedata to Biomarker Discovery Efforts

  • Syngenta expanded its biomarker discovery partnership with Genedata. It added the Genedata Expressionist Refiner MS module for LC/MS and GC/MS metabolomic raw data processing and analysis to its existing Genedata Expressionist system.

    Refiner MS expands Expressionist to process and analyze metabolomic raw MS data separately and in conjunction with microarray data, improving efficiency and enhancing the biomarker discovery process.

    Syngenta has been using the Genedata Expressionist Refiner Array and Analyst modules to process and analyze microarray data since 2005. With the rapid expansion of metabolomics research and the associated data volumes generated, Syngenta will now use Refiner MS to integrate MS data in its biomarker discovery projects.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »